BioNTech is a German biotechnology company known for developing and manufacturing innovative immunotherapies, particularly in the field of cancer treatment and infectious diseases. It gained significant global recognition for its role in creating one of the first effective mRNA-based vaccines for COVID-19, in collaboration with Pfizer. The company’s technology leverages messenger RNA to instruct cells to produce proteins that trigger an immune response, offering a novel approach to vaccination and immunotherapy. BioNTech’s broader research encompasses various therapeutic areas, aiming to harness the body’s immune system to combat diseases.
BioNTech transitions from its pandemic focus, targeting cancer treatment with mRNA technology. Despite declining profits in 2024, BioNTech's financial performance exceeded Wall Street expectations, reflecting resilience and adaptability. Projected revenue…